OpenAI Launches GPT-Rosalind — Its First AI Model Built Specifically for Drug Discovery and Life Sciences
OpenAI Launches GPT-Rosalind — Its First AI Model Built Specifically for Drug Discovery and Life Sciences

OpenAI officially launched GPT-Rosalind on April 17, 2026 — its first dedicated model in what the company is calling a new Life Sciences model series. The release isn't a general-public rollout. It's a tightly controlled research preview available exclusively to vetted enterprise organizations in the United States, and it comes with benchmark numbers that are drawing real attention from the biotech and pharmaceutical world.

2026-04-19Read
  • 1
  • 2
  • 3